Vimarsana
Biggest News Aggregation in the World

Page 34 - Comer Children News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Comer Children. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Comer Children Today - Breaking & Trending Today

Chicago shooting today: 3 teens among 4 seriously injured in Brainerd shooting near West 93rd Street and South Racine Avenue - Vimarsana News

Chicago shooting today: 3 teens among 4 seriously injured in Brainerd shooting near West 93rd Street and South Racine Avenue

Two teenagers and a man were injured in a Brainerd shooting in Chicago near 93rd and Racine, and the 16-year-old suspect was also hurt, police said.

Brainerd shooting leaves 3 teens, 1 adult hospitalized - Vimarsana News

Brainerd shooting leaves 3 teens, 1 adult hospitalized

An argument turned into a shooting in Brainerd, resulting in three teenagers and one adult being hospitalized. Two of the victims are in critical condition.

4 shot in Washington Heights home, teen boy in custody - Vimarsana News

4 shot in Washington Heights home, teen boy in custody

Three teenage boys, including a 16-year-old suspect, and a 21-year-old male were shot about 7 p.m. Monday at a home in the 9300 block of South Racine Avenue, police say.

Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease - Vimarsana News

Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) announced today that the U.S. Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 genome-edited cell therapy, for the treatment of sickle cell disease (SCD) in patients ...

Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY for the Treatment of Sickle Cell Disease - Vimarsana News

Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY for the Treatment of Sickle Cell Disease

BOSTON - Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics announced today that the U.S. Food and Drug Administration has approved CASGEVY , a CRISPR/Cas9 genome-edited cell therapy, for...